Elizabeth Heimrich

1.2k total citations
2 papers, 65 citations indexed

About

Elizabeth Heimrich is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Elizabeth Heimrich has authored 2 papers receiving a total of 65 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Genetics, 1 paper in Pathology and Forensic Medicine and 1 paper in Oncology. Recurrent topics in Elizabeth Heimrich's work include Lymphoma Diagnosis and Treatment (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Elizabeth Heimrich is often cited by papers focused on Lymphoma Diagnosis and Treatment (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Elizabeth Heimrich collaborates with scholars based in India and United States. Elizabeth Heimrich's co-authors include James R. Burke, Kathleen M. Gillooly, Lihong Cheng, Shailesh Dudhgaonkar, Aberra Fura, Mark A. Pattoli, Joseph A. Tino, Tracy Taylor, Stacey Skala and Scott H. Watterson and has published in prestigious journals such as Gastroenterology and PLoS ONE.

In The Last Decade

Elizabeth Heimrich

2 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Heimrich India	2	30	21	20	17	14	2	65
Dana Banas United States	2	29 1.0×	49 2.3×	22 1.1×	13 0.8×	14 1.0×	2	85
Esther Avery United States	4	41 1.4×	30 1.4×	19 0.9×	22 1.3×	18 1.3×	7	69
Gunilla Walldin Sweden	4	32 1.1×	31 1.5×	11 0.6×	46 2.7×	26 1.9×	12	86
Matthew McKinney United States	4	16 0.5×	35 1.7×	22 1.1×	16 0.9×	38 2.7×	6	90
Emily Sheldon‐Waniga United States	6	25 0.8×	9 0.4×	14 0.7×	7 0.4×	32 2.3×	12	76
Claudia Tandler Germany	5	20 0.7×	26 1.2×	8 0.4×	17 1.0×	27 1.9×	11	74
Jarosław Czyż Poland	6	20 0.7×	6 0.3×	23 1.1×	45 2.6×	33 2.4×	17	85
Sven Turkalj United Kingdom	5	40 1.3×	39 1.9×	31 1.6×	34 2.0×	47 3.4×	9	114
Adriana Zupa-Fernandez United States	3	22 0.7×	31 1.5×	6 0.3×	10 0.6×	42 3.0×	3	107
Chengqing Wu United States	7	23 0.8×	10 0.5×	30 1.5×	25 1.5×	46 3.3×	16	102

Countries citing papers authored by Elizabeth Heimrich

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Heimrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Heimrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Heimrich more than expected).

Fields of papers citing papers by Elizabeth Heimrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Heimrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Heimrich. The network helps show where Elizabeth Heimrich may publish in the future.

Co-authorship network of co-authors of Elizabeth Heimrich

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Heimrich. A scholar is included among the top collaborators of Elizabeth Heimrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Heimrich. Elizabeth Heimrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Xie, Jenny, Kathleen M. Gillooly, Xiaoxia Yang, et al.. (2018). 349 - BMS-986165 is a Highly Potent and Selective Allosteric Inhibitor of TYK2, Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. Gastroenterology. 154(6). S–1357. 18 indexed citations

2.

Gillooly, Kathleen M., Claudine Pulicicchio, Mark A. Pattoli, et al.. (2017). Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care. PLoS ONE. 12(7). e0181782–e0181782. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact